Mobile

Open-label trial of imatinib mesylate (Glivec, formerly known as STI571) in combination with vinorelbine (Navelbine) for patients with advanced breast carcinoma

Mise à jour : Il y a 4 ans
Référence : EUCTR2005-001537-15

Femme Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To assess the safety and tolerability of Glivec in combination with Vinorelbine in patients with progressive or metastatic breast cancer after previous anthracycline chemotherapy.

Critère d'inclusion

  • carcinoma breast

Liens